SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-19-014669
Filing Date
2019-07-11
Accepted
2019-07-11 16:07:44
Documents
1
Period of Report
2019-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 14869
  Complete submission text file 0001567619-19-014669.txt   16296
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Issuer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 9707 SHELBYVILLE ROAD LOUISVILLE KY 40233
Business Address
Schutte John (Reporting) CIK: 0001713580 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-10113 | Film No.: 19951255